{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:35:37Z","timestamp":1787024137136,"version":"build-2736575974"},"reference-count":42,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2131\/jts.42.427","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T18:34:02Z","timestamp":1499970842000},"page":"427-436","source":"Crossref","is-referenced-by-count":22,"title":["Mechanism-based risk assessment strategy for drug-induced cholestasis using the transcriptional benchmark dose derived by toxicogenomics"],"prefix":"10.2131","volume":"42","author":[{"given":"Taisuke","family":"Kawamoto","sequence":"first","affiliation":[{"name":"Safety Science Research, Kao Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ito","sequence":"additional","affiliation":[{"name":"Safety Science Research, Kao Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Morita","sequence":"additional","affiliation":[{"name":"Safety Science Research, Kao Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Honda","sequence":"additional","affiliation":[{"name":"Safety Science Research, Kao Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Benjamin, S.B., Ishak, K.G., Zimmerman, H.J. and Grushka, A. (1981): Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Hepatology, <b>1<\/b>, 255-263.","DOI":"10.1002\/hep.1840010311"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rnsson, E. and Olsson, R. (2005): Outcome and prognostic markers in severe drug-induced liver disease. Hepatology, <b>42<\/b>, 481-489.","DOI":"10.1002\/hep.20800"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Boverhof, D.R. and Zacharewski, T.R. (2006): Toxicogenomics in risk assessment: applications and needs. Toxicol. Sci., <b>89<\/b>, 352-360.","DOI":"10.1093\/toxsci\/kfj018"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chepelev, N.L., Moffat, I.D., Labib, S., Bourdon-Lacombe, J., Kuo, B., Buick, J.K., Lemieux, F., Malik, A.I., Halappanavar, S., Williams, A. and Yauk, C.L. (2015): Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study. Crit. Rev. Toxicol., <b>45<\/b>, 44-52.","DOI":"10.3109\/10408444.2014.973935"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Clewell, H.J., Efremenko, A., Campbell, J.L., Dodd, D.E. and Thomas, R.S. (2014): Transcriptional responses in the rat nasal epithelium following subchronic inhalation of naphthalene vapor. Toxicol. Appl. Pharmacol., <b>280<\/b>, 78-85.","DOI":"10.1016\/j.taap.2014.06.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Diehl, A.M., Latham, P., Boitnott, J.K., Mann, J. and Maddrey, W.C. (1984): Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases. Am. J. Med., <b>76<\/b>, 931-934.","DOI":"10.1016\/0002-9343(84)91013-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Dong, H., Gill, S., Curran, I.H., Williams, A., Kuo, B., Wade, M.G. and Yauk, C.L. (2016): Toxicogenomic assessment of liver responses following subchronic exposure to furan in Fischer F344 rats. Arch. Toxicol., <b>90<\/b>, 1351-1367.","DOI":"10.1007\/s00204-015-1561-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Driessen, M., Vitins, A.P., Pennings, J.L., Kienhuis, A.S., Water, B.V. and van der Ven, L.T. (2015): A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent <i>in vitro<\/i> and <i>in vivo<\/i> models using cyclosporine A, amiodarone and acetaminophen. Toxicol. Lett., <b>232<\/b>, 403-412.","DOI":"10.1016\/j.toxlet.2014.11.020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Fattinger, K., Funk, C., Pantze, M., Weber, C., Reichen, J., Stieger, B.and Meier, P.J. (2001): The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions. Clin. Pharmacol. Ther., <b>69<\/b>, 223-231.","DOI":"10.1067\/mcp.2001.114667"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Ferreira, F.M., Oliveira, P.J., Rolo, A.P., Santos, M.S., Moreno, A.J., da Cunha, M.F., Sei\u00e7a, R. and Palmeira, C.M. (2003): Cholestasis induced by chronic treatment with alpha-naphthyl-isothiocyanate (ANIT) affects rat renal mitochondrial bioenergetics. Arch. Toxicol., <b>77<\/b>, 194-200.","DOI":"10.1007\/s00204-003-0441-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Flowers, M.T., Groen, A.K., Oler, A.T., Keller, M.P., Choi, Y., Schueler, K.L., Richards, O.C., Lan, H., Miyazaki, M., Kuipers, F., Kendziorski, C.M., Ntambi, J.M. and Attie A.D. (2006): Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet. J. Lipid Res., <b>47<\/b>, 2668-2680.","DOI":"10.1194\/jlr.M600203-JLR200"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Fujii, T. (1997): Toxicological correlation between changes in blood biochemical parameters and liver histopathological findings. J. Toxicol. Sci., <b>22<\/b>, 161-183.","DOI":"10.2131\/jts.22.3_161"},{"key":"13","unstructured":"Funk, C., Pantze, M., Jehle, L., Ponelle, C., Scheuermann, G., Lazendic, M. and Gasser, R. (2001): Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate. Toxicology, <b>167<\/b>, 83-98."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Furihata, C., Watanabe, T., Suzuki, T., Hamada, S. and Nakajima, M. (2016): Collaborative studies in toxicogenomics in rodent liver in JEMS\u00b7MMS; a useful application of principal component analysis on toxicogenomics. Genes Environ., <b>38<\/b>, 1-15.","DOI":"10.1186\/s41021-016-0041-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Gautier, L., Cope, L., Bolstad, B.M. and Irizarry, R.A. (2004): affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, <b>20<\/b>, 307-315.","DOI":"10.1093\/bioinformatics\/btg405"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Gusenleitner, D., Auerbach, S.S., Melia, T., G\u00f3mez, H.F., Sherr, D.H. and Monti, S. (2014): Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action. PLoS One, <b>9<\/b>, 1-15.","DOI":"10.1371\/journal.pone.0102579"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hartmann, G., Cheung, A.K. and Piquette-Miller, M. (2002): Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther., <b>303<\/b>, 273-281.","DOI":"10.1124\/jpet.102.039404"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hirode, M., Horinouchi, M., Uehara, T., Ono, A., Miyagishima, T., Yamada, H., Nagao, T., Ohno, Y. and Urushidani, T. (2009): Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin. Hum. Exp. Toxicol., <b>28<\/b>, 231-244.","DOI":"10.1177\/0960327109104528"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Hong, F., Breitling, R., McEntee, C.W., Wittner, B.S., Nemhauser, J.L. and Chory, J. (2006): RankProd: A bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics, <b>22<\/b>, 2825-2827.","DOI":"10.1093\/bioinformatics\/btl476"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Igarashi, Y., Nakatsu, N., Yamashita, T., Ono, A., Ohno, Y., Urushidani, T. and Yamada, H. (2015): Open TG-GATEs: A large-scale toxicogenomics database. Nucleic Acids Res., <b>43<\/b>, D921-D927.","DOI":"10.1093\/nar\/gku955"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J.Jr. and Tugendreich, S. (2014): Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics, <b>30<\/b>, 523-530.","DOI":"10.1093\/bioinformatics\/btt703"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Liu, S., Kawamoto, T., Morita, O., Yoshinari, K. and Honda, H. (2017): Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. Toxicol. Appl. Pharmacol., <b>318<\/b>, 79-87.","DOI":"10.1016\/j.taap.2017.01.006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Matsumoto, H., Saito, F. and Takeyoshi, M. (2014): CARCINOscreen\u00ae: New short-term prediction method for hepatocarcinogenicity of chemicals based on hepatic transcript profiling in rats. J. Toxicol. Sci., <b>39<\/b>, 725-734.","DOI":"10.2131\/jts.39.725"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Morgan, R.E., Trauner, M., van Staden, C.J., Lee, P.H., Ramachandran, B., Eschenberg, M., Afshari, C.A., Qualls, C.W.Jr., Lightfoot-Dunn, R. and Hamadeh, H.K. (2010): Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol. Sci., <b>118<\/b>, 485-500.","DOI":"10.1093\/toxsci\/kfq269"},{"key":"25","unstructured":"National Research Council (US) Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology. (2007): Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Nemes, K., \u00c5berg, F., Gylling, H. and Isoniemi, H. (2016): Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications. World J. Hepatol., <b>8<\/b>, 924-932.","DOI":"10.4254\/wjh.v8.i22.924"},{"key":"27","unstructured":"Organisation for Economic Co-operation and Development. (2016): Users&apos; Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Ogimura, E., Sekine, S. and Horie, T. (2011): Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochem. Biophys. Res. Commun., <b>416<\/b>, 313-317.","DOI":"10.1016\/j.bbrc.2011.11.032"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B. and Heller, A. (2000): Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol., <b>32<\/b>, 56-67.","DOI":"10.1006\/rtph.2000.1399"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Ozer, J., Ratner, M., Shaw, M., Bailey, W. and Schomaker, S. (2008): The current state of serum biomarkers of hepatotoxicity. Toxicology, <b>245<\/b>, 194-205.","DOI":"10.1016\/j.tox.2007.11.021"},{"key":"31","unstructured":"Scientific Committee on Consumer Safety NfG (2016): The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation. SCCS\/1564\/15."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Padda, M.S., Sanchez, M., Akhtar, A.J. and Boyer, J.L. (2011): Drug-induced cholestasis. Hepatology, <b>53<\/b>, 1377-1387.","DOI":"10.1002\/hep.24229"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Suzuki, R. and Shimodaira, H. (2006): Pvclust: An R package for assessing the uncertainty in hierarchical clustering. Bioinformatics, <b>22<\/b>, 1540-1542.","DOI":"10.1093\/bioinformatics\/btl117"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Thomas, R.S., Wesselkamper, S.C., Wang, N.C., Zhao, Q.J., Petersen, D.D., Lambert, J.C., Cote, I., Yang, L., Healy, E., Black, M.B., Clewell, H.J.3rd., Allen, B.C. and Andersen, M.E. (2013): Temporal concordance between apical and transcriptional points of departure for chemical risk assessment. Toxicol. Sci., <b>134<\/b>, 180-194.","DOI":"10.1093\/toxsci\/kft094"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Van den Hof, W.F., Coonen, M.L., van Herwijnen, M., Brauers, K., Wodzig, W.K., van Delft, J.H. and Kleinjans, J.C. (2014a): Classification of hepatotoxicants using HepG2 cells: A proof of principle study. Chem. Res. Toxicol., <b>27<\/b>, 433-442.","DOI":"10.1021\/tx4004165"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Van den Hof, W.F., Van Summeren, A., Lommen, A., Coonen, M.L., Brauers, K., van Herwijnen, M., Wodzig, W.K. and Kleinjans, J.C. (2014b): Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity. Toxicology, <b>324<\/b>, 18-26.","DOI":"10.1016\/j.tox.2014.06.003"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Van den Hof, W.F., Ruiz-Aracama, A., Van Summeren, A., Jennen, D.G., Gaj, S., Coonen, M.L., Brauers, K., Wodzig, W.K., van Delft, J.H. and Kleinjans, J.C. (2015): Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity<i> in vitro<\/i>. Toxicol. In Vitro, <b>29<\/b>, 489-501.","DOI":"10.1016\/j.tiv.2014.12.016"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Vinken, M., Pauwels, M, Ates, G., Vivier, M., Vanhaecke, T. and Rogiers, V. (2012): Screening of repeated dose toxicity data present in SCC(NF)P\/SCCS safety evaluations of cosmetic ingredients. Arch. Toxicol., <b>86<\/b>, 405-412.","DOI":"10.1007\/s00204-011-0769-z"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Vinken, M., Landesmann, B., Goumenou, M., Vinken, S., Shah, I., Jaeschke, H., Willett, C., Whelan, M. and Rogiers. V. (2013): Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. Toxicol. Sci., <b>136<\/b>, 97-106.","DOI":"10.1093\/toxsci\/kft177"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Wang, Y., Lin, Z., Liu, Z., Harris, S., Kelly, R., Zhang, J., Ge, W., Chen, M., Borlak, J. and Tong, W. (2013): A unifying ontology to integrate histological and clinical observations for drug-induced liver injury. Am. J. Pathol., <b>182<\/b>, 1180-1187.","DOI":"10.1016\/j.ajpath.2012.12.033"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Watanabe, T., Suzuki, T., Natsume, M., Nakajima, M., Narumi, K., Hamada, S., Sakuma, T., Koeda, A., Oshida, K., Miyamoto, Y., Maeda, A., Hirayama, M., Sanada, H., Honda, H., Ohyama, W., Okada, E., Fujiishi, Y., Sutou, S., Tadakuma, A., Ishikawa, Y., Kido, M., Minamiguchi, R., Hanahara, I., and Furihata, C. (2012): Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR. Mutat. Res., <b>747<\/b>, 164-175.","DOI":"10.1016\/j.mrgentox.2012.04.011"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Yang, L., Allen, B.C. and Thomas, R.S. (2007): BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics, <b>8<\/b>, 387.","DOI":"10.1186\/1471-2164-8-387"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/4\/42_427\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:19:39Z","timestamp":1569802779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/4\/42_427\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.42.427","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}